FDA TO RELY ON EMA INSPECTION DATA FOR SOME DRUG FACILITIES

Abstract

The latest initiative, building on a pilot project, allows FDA to accept data from GMP inspections performed by the European Medicines Agency in Europe, and for the EMA to accept inspection data for sites in the United States performed by FDA, for historically compliant facilities that are known to both authorities.